Researchers are conducting a study for adults aged 18 and older who have multiple myeloma, a type of blood cancer that affects plasma cells. This study aims to test an investigational medication to see how well it works and how safe it is for people with this condition.
Key Points:
- The study lasts about 12 months, and participants will need to attend around 10 visits during this time.
- Participants must have been diagnosed with multiple myeloma and may need to meet other health criteria.
- There may be risks involved, and the study team will provide detailed information before you decide to join.
If you are interested and meet the age and condition criteria, you might consider participating. Keep in mind the time commitment and discuss with your healthcare provider to see if this study is suitable for you.
How understandable was the trial content above?
Hard to understand
Easy to understand